Sectors

KVUE
Kenvue Inc.
19.55
73 x 19.55
96 x 19.56
bid
ask
-
0.33
1.66%
03:16 PM
timesize
Ytd13.33%
1y29.56%
19.39
day range
19.84
14.24
52 week range
19.88
Open19.77Prev Close19.88Low19.39High19.84Mkt Cap37.57B
Vol7.31MAvg Vol22.74MEPS0.86P/E22.74Forward P/E16.05
Beta0.48Short Ratio2.18Inst. Own95.79%Dividend0.84Div Yield4.36
Ex Div Date09-21Earning10-3050-d Avg18.35200-d Avg18.121yr Est19.50
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-302026-090.29N/AN/AN/A
2026-08-062026-060.320.31-0.01-2.73%
2026-05-072026-030.260.320.0622.09%
2026-02-172025-120.220.270.0521.24%
2025-11-032025-090.260.280.027.61%
2025-08-072025-060.280.290.012.95%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-11UBSUpgradeNeutralNeutral
2026-07-21BarclaysUpgradeEqual-WeightEqual-Weight
2026-07-16UBSUpgradeNeutralNeutral
2026-04-15CitigroupUpgradeNeutralNeutral
2026-04-14BarclaysUpgradeEqual-WeightEqual-Weight
2026-04-07UBSUpgradeNeutralNeutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2026-03-09ALVARADO LUANIChief Operating Officer61.42KConversion of Exercise of derivative security
2026-10-01LAWSON CARLTONOfficer148.01KStock Award(Grant)
2025-03-04MONGON THIBAUTChief Executive Officer216.47KConversion of Exercise of derivative security
2025-12-14PERRY KIRK LChief Executive Officer62.55KConversion of Exercise of derivative security
2025-03-04RUH PAULChief Financial Officer56.20KConversion of Exercise of derivative security
2025-12-11SMITH JEFFREY CHADDirector0.00Purchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29FMR, LLC157.05M3.12B8.18%
2026-06-29Blackrock Inc.150.83M3.00B7.85%
2026-06-29Vanguard Capital Management LLC125.31M2.49B6.52%
2026-06-29State Street Corporation121.62M2.42B6.33%
2026-06-29Vanguard Portfolio Management LLC93.30M1.86B4.86%
2026-06-29Geode Capital Management, LLC52.02M1.03B2.71%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund60.96M1.21B3.17%
2026-06-29VANGUARD INDEX FUNDS-Vanguard 500 Index Fund49.76M989.65M2.59%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund41.60M827.51M2.17%
2026-08-30iShares Trust-iShares Core S&P 500 ETF25.57M508.54M1.33%
2026-08-30Fidelity Concord Street Trust-Fidelity 500 Index Fund24.92M495.73M1.30%
2026-09-29SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust23.82M473.79M1.24%
Dividend
DividendDate
0.212026-09-21
0.212026-08-12
0.20752026-05-13
0.20752026-02-11
0.20752025-11-12
0.20752025-08-13